EIGR
Eiger BioPharmaceuticals, Inc.
EIGR
EIGR
Delisted
EIGR was delisted on the 10th of April, 2024.
47 hedge funds and large institutions have $60.4M invested in Eiger BioPharmaceuticals, Inc. in 2016 Q3 according to their latest regulatory filings, with 7 funds opening new positions, 27 increasing their positions, 3 reducing their positions, and 5 closing their positions.
New
Increased
Maintained
Reduced
Closed
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
more funds holding in top 10
Funds holding in top 10: →
more first-time investments, than exits
New positions opened: | Existing positions closed:
more funds holding
Funds holding: →
6% less capital invested
Capital invested by funds: $64.3M → $60.4M (-$3.88M)
Holders
47
Holding in Top 10
2
Calls
–
Puts
–
Top Buyers
| 1 | +$4.25M | |
| 2 | +$3.79M | |
| 3 | +$3.19M | |
| 4 |
Wellington Management Group
Boston,
Massachusetts
|
+$3.02M |
| 5 |
BOTOTLSJU
Board of Trustees of The Leland Stanford Junior University
Redwood City,
California
|
+$1.86M |
Top Sellers
| 1 | -$281K | |
| 2 | -$241K | |
| 3 | -$68.9K | |
| 4 |
Citigroup
New York
|
-$7.14K |
| 5 |
Creative Planning
Overland Park,
Kansas
|
-$6.63K |